DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/043314/global_liver_cance) has announced the addition of the "Global Liver Cancer Drug Pipeline Capsule - 2012" report to their offering.
Fore Pharma's latest report Global Liver Cancer Drug Pipeline Capsule - 2012' is an outline of all the key research and development (R&D) activities of the global Liver Cancer drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.
The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the Liver Cancer drug market is thoroughly covered by company and licensee with the deal summary.
Key Topics Covered:
- Liver Cancer: Overview
- Liver Cancer Drug Pipeline Overview
- Liver Cancer Phase 3 Clinical Trial Drug Pipeline Insights
- Liver Cancer Phase 2 Clinical Trial Drug Pipeline Insights
- Liver Cancer Phase 1 Clinical Trial Drug Pipeline Insights
- Liver Cancer Preclinical Research Drug Pipeline Insights
- Liver Cancer Drug Discovery Pipeline Insights
- Geographic Landscape of Liver Cancer R&D Activities
- Liver Cancer R&D Activities in North America
- Liver Cancer R&D Activities in Europe
- Licensing Activities / Partnerships in the Global Liver Cancer Drug Market
Who and Why Should Buy This Report:
This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.
For more information visit http://www.researchandmarkets.com/research/043314/global_liver_cance